LMG Life Sciences 2023 Recognizes Gibson Dunn in Six Practices and Names 14 Lawyers Stars

September 27, 2023

The 2023 edition of LMG Life Sciences highlighted six Gibson Dunn practices – Antitrust, Corporate, General Patent Litigation, Hatch-Waxman Patent Litigation (Branded), Mergers and Acquisitions, and White-Collar/Government Investigations – in the area of Life Sciences. The guide recognized 14 Gibson Dunn lawyers as “Life Science Stars” including Century City partner Wayne Barsky, New York partners Barbara Becker, Reed Brodsky, Charlotte Jacobsen, Jane Love, Saee Muzumdar, Daniel Thomasch, and Robert Trenchard, Orange County partner Jeffrey Thomas, Palo Alto partner Joseph Barbeau, and San Francisco partners Branden Berns (Rising Star), Winston Chan, Ryan Murr, and Karen Spindler. The rankings were published on September 22, 2023.

The Life Sciences Practice Group represents and advises innovative biotechnology, pharmaceutical and medical device companies on a wide range of legal, regulatory and strategic issues, including patent and product liability litigation, U.S. Food and Drug Administration (FDA) investigations and enforcement actions, and corporate transactions and financings.